Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Small

Showing results (661-670 of 765) with videos related to

Pageof 77
Sort By:
JAMA|March 22, 1995
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer diseaseG W Small, J C Mazziotta, M T Collins, et al.
Annals of the New York Academy of Sciences|December 16, 1996
Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimagingG W Small, S Komo, A La Rue, et al.
Molecular Genetics and Metabolism|December 19, 2003
Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PETDaniel H S Silverman, Co T Truong, Shanna K Kim, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 19, 2011
The memory fitness program: cognitive effects of a healthy aging interventionKaren J Miller, Prabha Siddarth, Jean M Gaines, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
Serotonin 1A receptors in the living brain of Alzheimer's disease patientsVladimir Kepe, Jorge R Barrio, Sung-Cheng Huang, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 30, 2006
Effects of a 14-day healthy longevity lifestyle program on cognition and brain functionGary W Small, Daniel H S Silverman, Prabha Siddarth, et al.
Journal of Alzheimer'S Disease : JAD|February 6, 2013
Vascular risk and FDDNP-PET influence cognitive performanceDavid A Merrill, Prabha Siddarth, Vladimir Kepe, et al.
Archives of Neurology|February 15, 2012
Prediction of cognitive decline by positron emission tomography of brain amyloid and tauGary W Small, Prabha Siddarth, Vladimir Kepe, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2015
In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imagingJorge R Barrio, Gary W Small, Koon-Pong Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myelomaPeter M Voorhees, Qing Chen, Deborah J Kuhn, et al.
Pageof 77

Showing results (661-670 of 765) with videos related to

Sort By:
Pageof 77
JAMA|March 22, 1995
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer diseaseG W Small, J C Mazziotta, M T Collins, et al.
Annals of the New York Academy of Sciences|December 16, 1996
Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimagingG W Small, S Komo, A La Rue, et al.
Molecular Genetics and Metabolism|December 19, 2003
Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PETDaniel H S Silverman, Co T Truong, Shanna K Kim, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|July 19, 2011
The memory fitness program: cognitive effects of a healthy aging interventionKaren J Miller, Prabha Siddarth, Jean M Gaines, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
Serotonin 1A receptors in the living brain of Alzheimer's disease patientsVladimir Kepe, Jorge R Barrio, Sung-Cheng Huang, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 30, 2006
Effects of a 14-day healthy longevity lifestyle program on cognition and brain functionGary W Small, Daniel H S Silverman, Prabha Siddarth, et al.
Journal of Alzheimer'S Disease : JAD|February 6, 2013
Vascular risk and FDDNP-PET influence cognitive performanceDavid A Merrill, Prabha Siddarth, Vladimir Kepe, et al.
Archives of Neurology|February 15, 2012
Prediction of cognitive decline by positron emission tomography of brain amyloid and tauGary W Small, Prabha Siddarth, Vladimir Kepe, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 8, 2015
In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imagingJorge R Barrio, Gary W Small, Koon-Pong Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myelomaPeter M Voorhees, Qing Chen, Deborah J Kuhn, et al.
Pageof 77